ATE455795T1 - Neue cyclodextrinderivate, herstellungsverfahren dafür und verwendung davon zur solubilisierung von pharmakologisch wirksamen substanzen - Google Patents

Neue cyclodextrinderivate, herstellungsverfahren dafür und verwendung davon zur solubilisierung von pharmakologisch wirksamen substanzen

Info

Publication number
ATE455795T1
ATE455795T1 AT04742303T AT04742303T ATE455795T1 AT E455795 T1 ATE455795 T1 AT E455795T1 AT 04742303 T AT04742303 T AT 04742303T AT 04742303 T AT04742303 T AT 04742303T AT E455795 T1 ATE455795 T1 AT E455795T1
Authority
AT
Austria
Prior art keywords
solubilizing
new
production process
active substances
pharmacologically active
Prior art date
Application number
AT04742303T
Other languages
German (de)
English (en)
Inventor
Jacques Defaye
Carmen Ortiz-Mellet
Jose Manuel Garcia-Fernandez
Maria Gomez-Garcia
Kazimierz Chmurski
Jian-Xin Yu
Original Assignee
Centre Nat Rech Scient
Univ Grenoble 1
Consejo Superior Investigacion
Univ Sevilla
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Univ Grenoble 1, Consejo Superior Investigacion, Univ Sevilla filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE455795T1 publication Critical patent/ATE455795T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT04742303T 2003-03-28 2004-03-22 Neue cyclodextrinderivate, herstellungsverfahren dafür und verwendung davon zur solubilisierung von pharmakologisch wirksamen substanzen ATE455795T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0303899A FR2852959B1 (fr) 2003-03-28 2003-03-28 Nouveaux derives de cyclodextrines, leur procede de preparation et leur utilisation notamment pour solubilisation de substances pharmacologiquement actives
PCT/FR2004/000691 WO2004087768A1 (fr) 2003-03-28 2004-03-22 Nouveaux derives de cyclodextrines, leur procede de preparation et leur utilisation notamment pour la solubilisation de substances pharmacologiquement actives

Publications (1)

Publication Number Publication Date
ATE455795T1 true ATE455795T1 (de) 2010-02-15

Family

ID=32947275

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04742303T ATE455795T1 (de) 2003-03-28 2004-03-22 Neue cyclodextrinderivate, herstellungsverfahren dafür und verwendung davon zur solubilisierung von pharmakologisch wirksamen substanzen

Country Status (9)

Country Link
US (2) US7632941B2 (enExample)
EP (1) EP1608687B1 (enExample)
JP (1) JP5054970B2 (enExample)
AT (1) ATE455795T1 (enExample)
CA (1) CA2520391C (enExample)
DE (1) DE602004025213D1 (enExample)
ES (1) ES2338558T3 (enExample)
FR (1) FR2852959B1 (enExample)
WO (1) WO2004087768A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1735326A4 (en) * 2004-01-29 2011-04-20 Pinnacle Pharmaceuticals BETA-CYCLODEXTRIN DERIVATIVES AND THEIR USE AGAINST LETHAL ANTHRAX TOXIN
AU2005240122B2 (en) * 2004-05-03 2011-02-17 Omega Bio-Pharma (I.P.3) Limited Cysteamines for treating complications of hypercholesterolemia and diabetes
EP1846006A4 (en) 2005-01-28 2011-04-20 Pinnacle Pharmaceuticals Inc BETA-CYCLODEXTRIN DERIVATIVES AS ANTIBACTERIAL AGENTS
ES2294926B1 (es) * 2006-05-11 2009-02-16 Universidad De Sevilla Nuevos derivados de ciclodextrinas selectivamente funcionalizados en su cara secundaria, procedimiento de preparacion y utilizacion de los mismos.
FR2903987B1 (fr) * 2006-07-21 2012-12-21 Centre Nat Rech Scient Nouveaux derives de cyclodextrines amphiphiles, leur utilisation dans les domaines pharmaceutiques,cosmetiques, alimentaires et leur application a la production de nouveaux nanosystemes
WO2008116194A2 (en) * 2007-03-22 2008-09-25 Innovative Biologics, Inc. Blockers of pore-forming virulence factors and their use as anti-infectives
EP2328579B1 (en) * 2008-07-17 2013-10-23 The Johns Hopkins University Trioxane dimer sulfur compounds
US20100056475A1 (en) * 2008-08-06 2010-03-04 Alexander Chucholowski Cyclodextrin conjugates
CA2950610A1 (en) 2014-05-29 2015-12-03 Uti Limited Partnership Cyclodextrin-based polyanionic and non-ionic dendrimers
CN109762042B (zh) * 2018-09-21 2022-04-08 河北艾克美冀生物科技有限公司 一种治疗癌症的药物、其合成方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2648464B1 (fr) * 1989-06-14 1991-08-30 Commissariat Energie Atomique Derives de cyclomalto-oligosaccharides et leurs procedes de preparation
US5684169A (en) * 1992-11-27 1997-11-04 Ensuiko Sugar Refining Co., Ltd. Cyclodextrin inclusion complex of taxol, and method for its production and its use
JPH06157330A (ja) * 1992-11-27 1994-06-03 Ensuiko Sugar Refining Co Ltd タキソールのサイクロデキストリン包接物，その製造法と用途
US5959089A (en) * 1993-07-19 1999-09-28 Hannessian; Stephen Amino-cyclodextrin syntheses
FR2715307B1 (fr) * 1994-01-25 1996-04-05 Commissariat Energie Atomique Procédé de solubilisation dans un milieu aqueux d'agents antitumoraux de la famille du taxol, et cyclodextrines ramifiées utilisables pour cette solubilisation.
FR2716200B1 (fr) * 1994-02-11 1996-04-26 Commissariat Energie Atomique Procédé de préparation de cyclomaltooligosaccharides ramifiés, en particulier de cyclodextrines ramifiées.
FR2746103B1 (fr) * 1996-03-14 1998-07-24 Thioureido-cyclodextrines, utilisables en particulier pour solubiliser des agents antitumoraux et antiparasitaires et leurs procedes de preparation
US5770645A (en) * 1996-08-02 1998-06-23 Duke University Medical Center Polymers for delivering nitric oxide in vivo
US6157642A (en) 1997-10-14 2000-12-05 Teledesic Llc Coding system and method for low-earth orbit satellite data communication
FI980489A7 (fi) * 1998-03-04 1999-09-05 Alexei Radievich Khomutov Syklodekstriinien uudet johdannaiset

Also Published As

Publication number Publication date
CA2520391A1 (fr) 2004-10-14
FR2852959A1 (fr) 2004-10-01
EP1608687B1 (fr) 2010-01-20
JP2006521440A (ja) 2006-09-21
CA2520391C (fr) 2012-11-20
US20070167401A1 (en) 2007-07-19
ES2338558T3 (es) 2010-05-10
US20090264540A1 (en) 2009-10-22
WO2004087768A1 (fr) 2004-10-14
FR2852959B1 (fr) 2008-02-15
US8440814B2 (en) 2013-05-14
EP1608687A1 (fr) 2005-12-28
JP5054970B2 (ja) 2012-10-24
DE602004025213D1 (de) 2010-03-11
US7632941B2 (en) 2009-12-15

Similar Documents

Publication Publication Date Title
CY1105337T1 (el) Πρωτοτυπες διυδροπτepιδινονες, μεθοδος για την παραγωγη τους και η χρηση τους ως φαρμακευτικα μεσα
CY1108471T1 (el) Μεθοδος για την παραγωγη εστερων σκοπινης
CY1113578T1 (el) 2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια
NO20065178L (no) Tienopyridinderivater
ATE398125T1 (de) Chinazolin-derivate als tgf-beta-inhibitoren
DE50210313D1 (de) Amphotere sterole und deren verwendung
ATE291024T1 (de) Neue 4-aminofuropyrimidine und ihre verwendung
TW200504180A (en) Light-emitting element and iridium complex
CY1109232T1 (el) Νεα καρβαμυλιωμενη ερο και μεθοδος παραγωγης της
CY1113625T1 (el) Μεθοδος για την παραγωγη συμπυκνωμενων παραγωγων της πιπεραζιν-2-ονης καθως και ενδιαμεσα προϊοντα της μεθοδου
ATE347555T1 (de) 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung
DE60318583D1 (de) N-äphenyl(piperidin-2-yl)methylübenzamid-derivate, verfahren zu deren herstellung und ihre therapeutische verwendung
ATE455795T1 (de) Neue cyclodextrinderivate, herstellungsverfahren dafür und verwendung davon zur solubilisierung von pharmakologisch wirksamen substanzen
ATE536354T1 (de) Neuartige 1-aza-bizykloalkyl-derivate für die behandlung psychotischer und neurodegenerativer störungen
MXPA05011962A (es) Oxiarenos substituidos.
ATE460419T1 (de) Organosiliciumverbindungen, ihre herstellung und ihre verwendung
TW200503686A (en) Cannabinoid receptor modulator
DE502004002037D1 (de) Umgelagerte pentanole, ein verfahren zu ihrer herstellung und ihre verwendung als entz ndungshemmer
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
ATE399168T1 (de) Imidazopyridin-derivate und ihre verwendung als induzierbare no-synthase inhibitoren
ATE431328T1 (de) Photopolymerisierbare verbindungen
ATE349456T1 (de) Herstellung von 2-18f-2-desoxy-d-glucose durch festphasensynthese
ATE377594T1 (de) Oxathiincarboxamide
TW200728357A (en) Polycarbosilane, manufacture method of the same, silicon dioxide based composition for coatings and silicon dioxide film
ATE539762T1 (de) Aminosäureersatz für peptidkonstruktionen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties